Birnam Oak Advisors LP Takes Position in Amedisys, Inc. (NASDAQ:AMED)

Birnam Oak Advisors LP acquired a new stake in Amedisys, Inc. (NASDAQ:AMED) in the 4th quarter, HoldingsChannel.com reports. The fund acquired 174,383 shares of the health services provider’s stock, valued at approximately $15,832,000. Amedisys makes up 7.7% of Birnam Oak Advisors LP’s portfolio, making the stock its 6th largest holding.

Other institutional investors have also modified their holdings of the company. Blue Trust Inc. lifted its holdings in shares of Amedisys by 55.1% in the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider’s stock valued at $34,000 after buying an additional 124 shares during the period. HBW Advisory Services LLC acquired a new stake in shares of Amedisys in the fourth quarter valued at $38,000. Versant Capital Management Inc lifted its holdings in shares of Amedisys by 68.5% in the fourth quarter. Versant Capital Management Inc now owns 450 shares of the health services provider’s stock valued at $41,000 after buying an additional 183 shares during the period. KBC Group NV acquired a new stake in shares of Amedisys during the third quarter worth $63,000. Finally, Vestcor Inc acquired a new stake in shares of Amedisys during the fourth quarter worth $73,000. Institutional investors and hedge funds own 94.36% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Stephens reaffirmed an “equal weight” rating and set a $101.00 target price on shares of Amedisys in a research report on Tuesday, March 4th. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $100.75.

Amedisys Stock Up 0.1 %

Shares of Amedisys stock opened at $92.64 on Tuesday. The firm has a market capitalization of $3.04 billion, a PE ratio of 36.76, a price-to-earnings-growth ratio of 1.78 and a beta of 0.76. Amedisys, Inc. has a 12-month low of $82.15 and a 12-month high of $98.95. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The stock’s fifty day moving average is $92.16 and its 200-day moving average is $92.71.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings results on Wednesday, February 26th. The health services provider reported $0.96 earnings per share for the quarter, missing the consensus estimate of $1.05 by ($0.09). The business had revenue of $598.05 million for the quarter, compared to analyst estimates of $602.38 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. Equities analysts anticipate that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.